Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma

被引:613
作者
Chapuy, Bjoern [1 ]
McKeown, Michael R. [1 ]
Lin, Charles Y. [1 ]
Monti, Stefano [2 ]
Roemer, Margaretha G. M. [1 ]
Qi, Jun [1 ]
Rahl, Peter B. [3 ]
Sun, Heather H. [4 ]
Yeda, Kelly T. [1 ]
Doench, John G. [5 ]
Reichert, Elaine [1 ]
Kung, Andrew L. [6 ]
Rodig, Scott J. [4 ]
Young, Richard A. [3 ]
Shipp, Margaret A. [1 ]
Bradner, James E. [1 ]
机构
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Boston Univ, Sch Med, Sect Computat Biomed, Boston, MA 02118 USA
[3] MIT, Whitehead Inst Genome Res, Cambridge, MA 02142 USA
[4] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[5] Broad Inst, Cambridge, MA 02142 USA
[6] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA
基金
美国国家卫生研究院;
关键词
BET BROMODOMAIN INHIBITION; OCA-B; SELECTIVE-INHIBITION; GENE-EXPRESSION; P-TEFB; C-MYC; TRANSCRIPTION; LEUKEMIA; BRD4; CHROMATIN;
D O I
10.1016/j.ccr.2013.11.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diffuse large B cell lymphoma (DLBCL) is a biologically heterogeneous and clinically aggressive disease. Here, we explore the role of bromodomain and extra-terminal domain (BET) proteins in DLBCL, using integrative chemical genetics and functional epigenomics. We observe highly asymmetric loading of bromodomain 4 (BRD4) at enhancers, with approximately 33% of all BRD4 localizing to enhancers at 1.6% of occupied genes. These super-enhancers prove particularly sensitive to bromodomain inhibition, explaining the selective effect of BET inhibitors on oncogenic and lineage-specific transcriptional circuits. Functional study of genes marked by super-enhancers identifies DLBCLs dependent on OCA-B and suggests a strategy for discovering unrecognized cancer dependencies. Translational studies performed on a comprehensive panel of DLBCLs establish a therapeutic rationale for evaluating BET inhibitors in this disease.
引用
收藏
页码:777 / 790
页数:14
相关论文
共 51 条
[1]   Bromodomain and Extra-terminal (BET) Bromodomain Inhibition Activate Transcription via Transient Release of Positive Transcription Elongation Factor b (P-TEFb) from 7SK Small Nuclear Ribonucleoprotein [J].
Bartholomeeusen, Koen ;
Xiang, Yanhui ;
Fujinaga, Koh ;
Peterlin, B. Matija .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (43) :36609-36616
[2]   Roles of BCL6 in normal and transformed germinal center B cells [J].
Basso, Katia ;
Dalla-Favera, Riccardo .
IMMUNOLOGICAL REVIEWS, 2012, 247 :172-183
[3]   Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription [J].
Bisgrovet, Dwayne A. ;
Mahmoudi, Tokameh ;
Henklein, Peter ;
Verdin, Eric .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (34) :13690-13695
[4]   Metabolic Signatures Uncover Distinct Targets in Molecular Subsets of Diffuse Large B Cell Lymphoma [J].
Caro, Pilar ;
Kishan, Amar U. ;
Norberg, Erik ;
Stanley, Illana A. ;
Chapuy, Bjoern ;
Ficarro, Scott B. ;
Polak, Klaudia ;
Tondera, Daniel ;
Gounarides, John ;
Yin, Hong ;
Zhou, Feng ;
Green, Michael R. ;
Chen, Linfeng ;
Monti, Stefano ;
Marto, Jarrod A. ;
Shipp, Margaret A. ;
Danial, Nika N. .
CANCER CELL, 2012, 22 (04) :547-560
[5]   Introduction [J].
Chen, Ling .
MANAGEMENT COMMUNICATION QUARTERLY, 2013, 27 (01) :3-5
[6]   Pax5: the guardian of B cell identity and function [J].
Cobaleda, Cesar ;
Schebesta, Alexandra ;
Delogu, Alessio ;
Busslinger, Meinrad .
NATURE IMMUNOLOGY, 2007, 8 (05) :463-470
[7]   Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia [J].
Dawson, Mark A. ;
Prinjha, Rab K. ;
Dittmann, Antje ;
Giotopoulos, George ;
Bantscheff, Marcus ;
Chan, Wai-In ;
Robson, Samuel C. ;
Chung, Chun-wa ;
Hopf, Carsten ;
Savitski, Mikhail M. ;
Huthmacher, Carola ;
Gudgin, Emma ;
Lugo, Dave ;
Beinke, Soren ;
Chapman, Trevor D. ;
Roberts, Emma J. ;
Soden, Peter E. ;
Auger, Kurt R. ;
Mirguet, Olivier ;
Doehner, Konstanze ;
Delwel, Ruud ;
Burnett, Alan K. ;
Jeffrey, Phillip ;
Drewes, Gerard ;
Lee, Kevin ;
Huntly, Brian J. P. ;
Kouzarides, Tony .
NATURE, 2011, 478 (7370) :529-533
[8]   BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc [J].
Delmore, Jake E. ;
Issa, Ghayas C. ;
Lemieux, Madeleine E. ;
Rahl, Peter B. ;
Shi, Junwei ;
Jacobs, Hannah M. ;
Kastritis, Efstathios ;
Gilpatrick, Timothy ;
Paranal, Ronald M. ;
Qi, Jun ;
Chesi, Marta ;
Schinzel, Anna C. ;
McKeown, Michael R. ;
Heffernan, Timothy P. ;
Vakoc, Christopher R. ;
Bergsagel, P. Leif ;
Ghobrial, Irene M. ;
Richardson, Paul G. ;
Young, Richard A. ;
Hahn, William C. ;
Anderson, Kenneth C. ;
Kung, Andrew L. ;
Bradner, James E. ;
Mitsiades, Constantine S. .
CELL, 2011, 146 (06) :903-916
[9]   Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family [J].
Filippakopoulos, Panagis ;
Picaud, Sarah ;
Mangos, Maria ;
Keates, Tracy ;
Lambert, Jean-Philippe ;
Barsyte-Lovejoy, Dalia ;
Felletar, Ildiko ;
Volkmer, Rudolf ;
Mueller, Susanne ;
Pawson, Tony ;
Gingras, Anne-Claude ;
Arrowsmith, Cheryl H. ;
Knapp, Stefan .
CELL, 2012, 149 (01) :214-231
[10]   Selective inhibition of BET bromodomains [J].
Filippakopoulos, Panagis ;
Qi, Jun ;
Picaud, Sarah ;
Shen, Yao ;
Smith, William B. ;
Fedorov, Oleg ;
Morse, Elizabeth M. ;
Keates, Tracey ;
Hickman, Tyler T. ;
Felletar, Ildiko ;
Philpott, Martin ;
Munro, Shonagh ;
McKeown, Michael R. ;
Wang, Yuchuan ;
Christie, Amanda L. ;
West, Nathan ;
Cameron, Michael J. ;
Schwartz, Brian ;
Heightman, Tom D. ;
La Thangue, Nicholas ;
French, Christopher A. ;
Wiest, Olaf ;
Kung, Andrew L. ;
Knapp, Stefan ;
Bradner, James E. .
NATURE, 2010, 468 (7327) :1067-1073